RxMM Health Ltd. is the parent holding company of AgTech Global, Clerisy Corporation and RxMM Health Capital. RxMM Health has interests in Agricultural technology, proprietary medical devices and medicinal Cannabis operations and is currently undergoing the divestment of its subsidiary companies into multiple public listings.

The Company’s business strategy is a “Farm-to-Pharma” business acquisition model which includes:

  1. Cultivation and extraction (hemp & cannabis)
  2. New product formulations (OTC and prescription)
  3. Medically approved delivery devices
  4. Health & lifestyle dispensary centres

RxMM’s team are pursuing its mission to be the leader in medicinal cannabis markets.

  • Oct 2015
  • RxMM Health incorporated in Perth, Western Australia

  • Nov 2015
  • Strategic relationship with leading Greenhouse / Hydroponics Experts

  • Dec 2015
  • RxMM completed its initial private placement for development capital

  • Jan 2016
  • Appointed senior NYSE veteran & CNN News anchorman as its Chairman

  • Feb 2016
  • Commenced initial prescription fulfillment operations in Northern California

  • Mar 2016
  • Completed second private placement funding

  • Apr 2016
  • Executed binding HOA to acquire patented, FDA approved Aromahaler™ parent company – Clerisy Corporation

  • Contracted leading global design house for its lifestyle dispensary chain

  • Invested in Las Vegas market though PNTV / Green Leaf Farms

  • May 2016
  • Signed binding HOA to acquire a large Californian cannabis produce

  • Commenced a $4m Pre-IPO capital raise

  • Jun 2016
  • Signed option to acquire natural skincare & cosmetics company

  • Completed Divestment of Clerisy in Preparation for US Listing

corporate structure

Brian Harcourt

CEO

Mr Harcourt started his career in the banking and securities industry and then served as CEO of Western Underwriters Pty Ltd (one of Australia's largest private insurers, purchased by QBE). Mr Harcourt has been involved in Australia, Asia, UK and USA as a business developer and entrepreneur for over 40 years. Mr Harcourt has conducted IPOs, reverse mergers or business acquisitions in these countries and was the Co-Founder, Chairman and CEO of the Ramtron Group which developed breakthrough ferroelectric memory chip technology and manufacturing in Colorado, USA. He has also served as a Senior Advisor to one of the world's largest commodities traders and had major business dealings with Governments and Ministers in Russia, China and USA.

George Roth

COO

George is also presently Chairman of the Board of RxMM Health Inc., the subsidiary of RxMM Health Ltd. Previously he had formed and prepared his own companies to become publicly traded in a number of enterprises including MMJ testing laboratories, distillery product branding, and tankless hydrogen generation for the automotive industry. With a B.S. Electromechanical Engineering and a M.S. Industrial Administration, George is experienced in business development including design and execution of mergers and acquisitions, financial analysis and evaluation of corporate transactions; locating and creating sources of long term debt and equity capital; and mediation of legal and business disputes. As President of his consulting firm, Xion Corporation, he has been a respected source of assistance to microcap corporations and enterprises both public and private since 1970, directing the activities of attorneys, CPA’s, brokers, and compliance experts in creating solutions to critical market trading and capital formation requirements. Previous to his entry into the microcap arena, he spent 10 years as a Program Manager for a number of major Aerospace corporations involved in various classified military programs.

Frank Layton

EVP - Business Development

Frank has a diversified entrepreneurial background with over 30 years of business experience in real estate finance and securities and venture capital. During the 1980’s Frank represented real estate development companies as Vice President of Investor Relations and raised in excess of $200 million a year through NASD registered firms in the western United States. Moving onto the “Venture” arena in the 1990’s, Frank managed a series of successful capital raises for private companies in excess of $50 million. As a native Californian, Frank studied the beginnings of the Medical Marijuana Industry’s legal and market development from its early inception in 1996 through to its current rapid growth stage and his relationships have been instrumental in the early development of the Company.

Fiona Morgan

CFO

Fiona has 28 years of experience in finance, administration and corporate governance, working for a range of leading public and private companies in Australia, Singapore and the UK including Group Financial Controller of Integra Global and Financial Controller for Connor Solutions Ltd (Invensys) with an annual turnover of $400mm. Fiona is a Chartered Accountant and a Chartered Secretary and currently owns a Finance and Corporate Governance consultancy business in Perth. Fiona also has considerable non profit/not-for-profit experience, functioning as honorary Treasurer for BALYA, a cancer diagnosis & support organisation.

Alan Valdes

Chairman - Non Executive

Alan is a contributing editor for CNBC, is seen weekly on CNN, Bloomberg TV, World News Tonight, CBS Nightly News, Fox Business, Associated Press TV, and is a frequent guest on CBS Radio. Worldwide he is seen on French 1TV, Sky Channel in Australia, Bloomberg India, CCTV in China and Brazilian TV. On the Internet, he is on Reuters.com, Wall Street Multi Media, TheStreet.com, DowJones.com and is often quoted in the Wall Street Journal. Alan is Chairman; Diego Pellicer, a global leader in property acquisitions and leasing to the Cannabis Industry and Chairman; Wall Street Capital Partners, a boutique corporate finance advisory with offices in New York, London and Hong Kong. Alan also sits on the board of Huade International, is a director of Xheng Fa University Law School (Chinese Exchange Lecture Series), director of Huade Cavendish Gold Fund, a professor of business at New York Institute of Technology, executive committee member of the United Nations Council on Energy, a member of the Worldwide Water Foundation and holds an honorary degree from the Paris School of Business in France.

Brian Harcourt

CEO, Deputy Chairman

Mr Harcourt started his career in the banking and securities industry and then served as CEO of Western Underwriters Pty Ltd (one of Australia's largest private insurers, purchased by QBE). Mr Harcourt has been involved in Australia, Asia, UK and USA as a business developer and entrepreneur for over 40 years. Mr Harcourt has conducted IPOs, reverse mergers or business acquisitions in these countries and was the Co-Founder, Chairman and CEO of the Ramtron Group which developed breakthrough ferroelectric memory chip technology and manufacturing in Colorado, USA. He has also served as a Senior Advisor to one of the world's largest commodities traders and had major business dealings with Governments and Ministers in Russia, China and USA.

Ross Lyndon-James

Executive Director

Over a thirty five year entrepreneurial business career, Ross has co-founded, funded and developed a number of publicly traded companies encompassing breakthrough ferroelectric memory chip development and manufacturing, smartwatch & smart tag RFID technologies, renewable energy systems, reverse osmosis water treatment and Imax theaters. Unlisted companies include sport & leisure apparel manufacturing and hydroponic plant cultivation. He has extensive experience in the capital markets having conducted numerous IPOs, reverse mergers and business acquisitions in Australia, the United States and the United Kingdom in the capacities of Co-founder, Chairman, President and CEO.

David L. Felten MD., Ph.D

Director - Non Executive

David was recently Vice President, Research, and Medical Director of the Research Institute at Beaumont Health System, and the founding Associate Dean for research at the Oakland University William Beaumont School of Medicine. He oversaw the clinical translational research and basic research. Dr. Felten received a B.S. from the Massachusetts Institute of Technology in 1969, an M.D. from the University of Pennsylvania in 1973, and a Ph.D. in anatomy/neurosciences through the Institute for Neurological Sciences at the University of Pennsylvania in 1974. He has received numerous honors and awards, including the John D. and Catherine T. MacArthur Foundation Prize Fellowship, and two separate 10-year MERIT Awards from institutes (Aging, Mental Health) at the National Institutes of Health.

Get in Touch

Australia - Perth

45 Ventnor Avenue
West Perth, WA 6005

Tel: +61 8 9389 4413

United States - California

31642 Coast Highway, Suite 202
Laguna Beach, CA 92651

Tel: +1 (949) 456-3972

Last Issue Price

US$2.50

Price is in US dollars (USD).

As featured in:
The Australian
Sky News
Fairfax Media
The West Australian
Marijuana Business Daily